title: Arginine vasopressin regulation in pre- and postpubertal male rats by the androgen metabolite 3beta-diol.
abstract: Arginine vasopressin (AVP) is a nonapeptide expressed in several brain regions. In addition to its well-characterized role in osmoregulation, AVP regulates paternal behavior, aggression,circadian rhythms, and the stress response. In the bed nucleus of the stria terminalis (BST), AVP gene expression is tightly regulated by gonadal steroid hormones. However, the degree by which AVP is regulated by gonadal steroid hormones in the suprachiasmatic nucleus (SCN) and medial amygdala (MeA) is unclear. Previous studies have shown that AVP expression in the brain of gonadectomized rats is restored with testosterone, 17beta-estradiol, and 5alpha-dihydrotestosterone(DHT) replacement. In addition, we have demonstrated that 3beta-diol, a metabolite of DHT,increased AVP promoter activity in a neuronal cell line and that the effects of 3beta-diol on AVP promoter activity were mediated by estrogen receptor-beta. To test whether 3beta-diol has a physiological role in the regulation of central AVP expression in vivo, we gonadectomized pre- and postpubertal male rats and followed with once daily injections of estradiol benzoate (EB),DHT-propionate, 3beta-diol-dipropionate, or vehicle. The SCN, BST, and MeA were analyzed for AVP mRNA expression using in situ hybridization. In the BST, intact juveniles had significantly fewer AVP-expressing cells than adults. GDX abolished all AVP mRNA expression in the BST in both age groups, whereas treatment with EB restored >80% and DHTP <10% of the AVP expression. Interestingly, 3beta-diol-proprionate was more effective at inducing AVP expression in juveniles than in adults, suggesting that the regulation of AVP by 3beta-diol might be age dependent [corrected].
authors.affiliation: Dept. of Cell Biology, Loyola University Chicago, Stritch School of Medicine, 2160 S. First Ave., Maywood, IL 60153, USA. tpak@lumc.edu
authors.forename: Toni R
authors.initials: TR
authors.lastname: Pak
authors.forename: Wilson C J
authors.initials: WC
authors.lastname: Chung
authors.forename: Laura R
authors.initials: LR
authors.lastname: Hinds
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Handa
mesh_terms: D000679:Amygdala / Q000187:drug effects / Q000502:physiology; D045930:Anabolic Agents / Q000494:pharmacology*; D000728:Androgens / Q000502:physiology; D015113:Androstane-3,17-diol / Q000494:pharmacology*; D000818:Animals; D001127:Arginine Vasopressin / Q000235:genetics*; D001522:Behavior, Animal / Q000502:physiology; D001921:Brain / Q000187:drug effects* / Q000502:physiology*; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D008297:Male; D009919:Orchiectomy; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012686:Septal Nuclei / Q000187:drug effects / Q000502:physiology; D012741:Sexual Maturation / Q000502:physiology*; D013493:Suprachiasmatic Nucleus / Q000187:drug effects / Q000502:physiology; D013495:Supraoptic Nucleus / Q000187:drug effects / Q000502:physiology
chemical_list: D045930:Anabolic Agents; D000728:Androgens; D012333:RNA, Messenger; D001127:Arginine Vasopressin; D015113:Androstane-3,17-diol